1. Home
  2. BFK vs SIGA Comparison

BFK vs SIGA Comparison

Compare BFK & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BFK
  • SIGA
  • Stock Information
  • Founded
  • BFK N/A
  • SIGA 1995
  • Country
  • BFK United States
  • SIGA United States
  • Employees
  • BFK N/A
  • SIGA N/A
  • Industry
  • BFK Finance Companies
  • SIGA Biotechnology: Pharmaceutical Preparations
  • Sector
  • BFK Finance
  • SIGA Health Care
  • Exchange
  • BFK Nasdaq
  • SIGA Nasdaq
  • Market Cap
  • BFK 417.9M
  • SIGA 422.9M
  • IPO Year
  • BFK N/A
  • SIGA 1997
  • Fundamental
  • Price
  • BFK $9.49
  • SIGA $6.52
  • Analyst Decision
  • BFK
  • SIGA
  • Analyst Count
  • BFK 0
  • SIGA 0
  • Target Price
  • BFK N/A
  • SIGA N/A
  • AVG Volume (30 Days)
  • BFK 117.1K
  • SIGA 418.3K
  • Earning Date
  • BFK 01-01-0001
  • SIGA 07-31-2025
  • Dividend Yield
  • BFK 4.33%
  • SIGA 9.02%
  • EPS Growth
  • BFK N/A
  • SIGA N/A
  • EPS
  • BFK N/A
  • SIGA 0.67
  • Revenue
  • BFK N/A
  • SIGA $120,330,310.00
  • Revenue This Year
  • BFK N/A
  • SIGA N/A
  • Revenue Next Year
  • BFK N/A
  • SIGA $95.31
  • P/E Ratio
  • BFK N/A
  • SIGA $9.91
  • Revenue Growth
  • BFK N/A
  • SIGA N/A
  • 52 Week Low
  • BFK $8.55
  • SIGA $4.95
  • 52 Week High
  • BFK $10.48
  • SIGA $12.83
  • Technical
  • Relative Strength Index (RSI)
  • BFK 44.97
  • SIGA 57.63
  • Support Level
  • BFK $9.45
  • SIGA $6.01
  • Resistance Level
  • BFK $9.56
  • SIGA $6.49
  • Average True Range (ATR)
  • BFK 0.07
  • SIGA 0.25
  • MACD
  • BFK 0.00
  • SIGA 0.00
  • Stochastic Oscillator
  • BFK 40.63
  • SIGA 75.32

About BFK BlackRock Municipal Income Trust

Blackrock Municipal Income Trust is a closed-end municipal bond fund. Its investment objective is to provide current income exempt from regular U.S. federal income tax.

About SIGA SIGA Technologies Inc.

SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.

Share on Social Networks: